Filing Details

Accession Number:
0000899243-22-037275
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-01 16:05:19
Reporting Period:
2022-11-29
Accepted Time:
2022-12-01 16:05:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107421 Alaunos Therapeutics Inc. TCRT Pharmaceutical Preparations (2834) 841475642
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1827847 W Robert Postma C/O Alaunos Therapeutics, Inc.
8030 El Rio St.
Houston TX 77054
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-29 750,000 $0.65 5,000,000 No 4 P Indirect By WaterMill Asset Management Corp.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By WaterMill Asset Management Corp.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,241,870 Direct
Common Stock 3,574 Indirect By Spouse's IRA
Footnotes
  1. The shares are directly held by WaterMill Asset Management Corp. The Reporting Person serves as the principal of WaterMill Asset Management Corp.
  2. The shares were purchased in a registered underwritten offering on November 29, 2022.
  3. Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer.